Refractive surgery in the late-adulthood and adolescent age groups

Session Details

Session Title: SMILE vs PRK, Ocular Surface Disease

Session Date/Time: Monday 24/09/2018 | 08:00-10:30

Paper Time: 10:10

Venue: Room A3, Podium 3

First Author: : I.Hecht ISRAEL

Co Author(s): :    A. Achiron   M. Mimouni   Z. Burgansky-Eliash   I. Kaiserman           

Abstract Details

Purpose:

Refractive surgery is becoming more common in the late-adulthood and adolescent age groups, however less is known about the outcomes in these populations. Our aim was to describe the outcomes of refractive surgery in patients over the age of 60 and between the ages of 12-17 compared to a control group of patients aged 20-40.

Setting:

We used data on consecutive patients who underwent LASIK or PRK by multiple surgeons between January 2005 and December 2016 at Care-Vision Laser Centers, Tel-Aviv, Israel.

Methods:

We performed a retrospective cohort analysis of 80,895 consecutive cases of 39,501 patients who underwent laser-assisted in situ keratomileusis and photorefractive keratectomy during a 16-year period in a single center. We characterized the populations and calculated and compared the safety, efficacy and retreatment rates.

Results:

Included in the analysis were 307 patients above the age of 60, 764 patients aged 12-17 and 62,215 patients aged 20-40. Older patients generally had worse safety outcomes (percent of cases with a safety index <0.5: 3.8% vs 0.2%, P<0.001), lower efficacy index (0.81±0.3 vs 0.96±0.3, P<0.001) and higher retreatment rates (6.3% vs 2.1%, P<0.001) compared to patients aged 20-40. In adolescents the outcomes were comparable to patients aged 20-40, however they had a higher percentage of cases with a safety index below 0.5 (0.8% vs 0.2%, P=0.001).

Conclusions:

Refractive surgery in the late-adulthood population of our cohort resulted in less satisfactory safety and efficacy outcomes with a higher retreatment rates. In adolescents results were comparable to those achieved in the general population.

Financial Disclosure:

-